OBJECTIVE: To describe reduced penetrance associated with early onset in a Brazilian family with spinocerebellar ataxia type 10. DESIGN: Clinical examination and molecular analysis for the ATTCT repeat responsible for spinocerebellar ataxia type 10 in a patient and family members through 3 generations. SETTING: Ambulatory care. Patients A 28-year-old female Brazilian patient who presented with early-onset cerebellar ataxia and epilepsy, and her 9 asymptomatic relatives. Main Outcome Measure Genotype-phenotype correlation. RESULTS: Molecular testing on this patient showed an expansion of approximately 850 ATTCT repeats at the SCA10 locus. Similar SCA10 expansions of approximately 850 repeats were identified in 6 of 8 asymptomatic paternal relatives examined. CONCLUSION: The stably transmitted pentanucleotide expansion of approximately 850 repeats may represent a mutant SCA10 allele with reduced penetrance that may express an early-onset, severe phenotype.
OBJECTIVE: To describe reduced penetrance associated with early onset in a Brazilian family with spinocerebellar ataxia type 10. DESIGN: Clinical examination and molecular analysis for the ATTCT repeat responsible for spinocerebellar ataxia type 10 in a patient and family members through 3 generations. SETTING: Ambulatory care. Patients A 28-year-old female Brazilian patient who presented with early-onset cerebellar ataxia and epilepsy, and her 9 asymptomatic relatives. Main Outcome Measure Genotype-phenotype correlation. RESULTS: Molecular testing on this patient showed an expansion of approximately 850 ATTCT repeats at the SCA10 locus. Similar SCA10 expansions of approximately 850 repeats were identified in 6 of 8 asymptomatic paternal relatives examined. CONCLUSION: The stably transmitted pentanucleotide expansion of approximately 850 repeats may represent a mutant SCA10 allele with reduced penetrance that may express an early-onset, severe phenotype.
Authors: Hélio A G Teive; Renato P Munhoz; Salmo Raskin; Walter O Arruda; Luciano de Paola; Lineu C Werneck; Tetsuo Ashizawa Journal: Mov Disord Date: 2010-12-15 Impact factor: 10.338
Authors: Giovana B Bampi; Rafael Bisso-Machado; Tábita Hünemeier; Tailise C Gheno; Gabriel V Furtado; Diego Veliz-Otani; Mario Cornejo-Olivas; Pillar Mazzeti; Maria Cátira Bortolini; Laura B Jardim; Maria Luiza Saraiva-Pereira Journal: Neuromolecular Med Date: 2017-09-13 Impact factor: 3.843
Authors: Misti C White; Rui Gao; Weidong Xu; Santi M Mandal; Jung G Lim; Tapas K Hazra; Maki Wakamiya; Sharon F Edwards; Salmo Raskin; Hélio A G Teive; Huda Y Zoghbi; Partha S Sarkar; Tetsuo Ashizawa Journal: PLoS Genet Date: 2010-06-10 Impact factor: 5.917
Authors: Roberto Rodríguez-Labrada; Ana Carolina Martins; Jonathan J Magaña; Yaimeé Vazquez-Mojena; Jacqueline Medrano-Montero; Juan Fernandez-Ruíz; Bulmaro Cisneros; Helio Teive; Karen N McFarland; Maria Luiza Saraiva-Pereira; César M Cerecedo-Zapata; Christopher M Gomez; Tetsuo Ashizawa; Luis Velázquez-Pérez; Laura Bannach Jardim Journal: Cerebellum Date: 2020-06 Impact factor: 3.847
Authors: Raphael Machado de Castilhos; Gabriel Vasata Furtado; Tailise Conte Gheno; Paola Schaeffer; Aline Russo; Orlando Barsottini; José Luiz Pedroso; Diego Z Salarini; Fernando Regla Vargas; Maria Angélica de Faria Domingues de Lima; Clécio Godeiro; Luiz Carlos Santana-da-Silva; Maria Betânia Pereira Toralles; Silvana Santos; Hélio van der Linden; Hector Yuri Wanderley; Paula Frassineti Vanconcelos de Medeiros; Eliana Ternes Pereira; Erlane Ribeiro; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim Journal: Cerebellum Date: 2014-02 Impact factor: 3.847